Research ArticleClinical Sciences
Biodistribution and In Vivo Kinetics of Iodine-131 Lipiodol Infused via the Hepatic Artery of Patients with Hepatic Cancer
Masayuki Nakajo, Hisashi Kobayashi, Kunisada Shimabukuro, Kazuo Shirono, Hiromichi Sakata, Masato Taguchi, Noriaki Uchiyama, Toshihide Sonoda and Shinji Shinohara
Journal of Nuclear Medicine June 1988, 29 (6) 1066-1077;
Masayuki Nakajo
Hisashi Kobayashi
Kunisada Shimabukuro
Kazuo Shirono
Hiromichi Sakata
Masato Taguchi
Noriaki Uchiyama
Toshihide Sonoda
This article has a correction. Please see:
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Biodistribution and In Vivo Kinetics of Iodine-131 Lipiodol Infused via the Hepatic Artery of Patients with Hepatic Cancer
Masayuki Nakajo, Hisashi Kobayashi, Kunisada Shimabukuro, Kazuo Shirono, Hiromichi Sakata, Masato Taguchi, Noriaki Uchiyama, Toshihide Sonoda, Shinji Shinohara
Journal of Nuclear Medicine Jun 1988, 29 (6) 1066-1077;
Biodistribution and In Vivo Kinetics of Iodine-131 Lipiodol Infused via the Hepatic Artery of Patients with Hepatic Cancer
Masayuki Nakajo, Hisashi Kobayashi, Kunisada Shimabukuro, Kazuo Shirono, Hiromichi Sakata, Masato Taguchi, Noriaki Uchiyama, Toshihide Sonoda, Shinji Shinohara
Journal of Nuclear Medicine Jun 1988, 29 (6) 1066-1077;
Jump to section
Related Articles
Cited By...
- Advantage of 188Re-Radiopharmaceuticals in Hepatocellular Cancer and Liver Metastases
- 188Re-HDD/Lipiodol Therapy for Hepatocellular Carcinoma: A Phase I Clinical Trial
- Lipiodol Solution of 188Re-HDD as a New Therapeutic Agent for Transhepatic Arterial Embolization in Liver Cancer: Preclinical Study in a Rabbit Liver Cancer Model